Cite
HARVARD Citation
Pinato, D. et al. (n.d.). Applicability of Routine Targeted Next-generation Sequencing to Estimate Tumor Mutational Burden (TMB) in Patients Treated With Immune Checkpoint Inhibitor Therapy. Journal of immunotherapy. 43 (2), p. . [Online].